In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

“mRNA technology will complement existing vaccine technology ... but it’s possible for H5N1 to swap genetic material with a human seasonal flu virus and spawn a new form of influenza with pandemic ...

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

A research team led by Professor Won Jong Kim from the Department of Chemistry at POSTECH, in collaboration with the Korea ...

But scientists at Moderna are in the late stages of testing what could be the first such shot, using mRNA technology against the virus. Here’s what to know about norovirus and where things stand ...

that closely resemble norovirus but which contain no actual virus. The candidate uses the same basic mRNA technology implemented in Moderna’s covid-19 vaccines to accomplish this. mRNA vaccines ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed ...

HONG KONG SAR - Media OutReach Newswire – 5 February 2025 - AIM Vaccine Co., Ltd. (06660), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory ...